Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

Guo-Ming Shi; Jiping Wang; Xiao-Wu Huang; Xiao-Yong Huang; Yi-Feng He; Yuan Ji; Yi Chen; Dong Wu; Jia-Cheng Lu; Qi-Man Sun; Wei-Ren Liu; Ting Wang; Liu-Xiao Yang; Ying-Yong Hou; Ying-Hong Shi; Jian Sun; Yong-Sheng Xiao; Zheng Wang; Jia Fan; Monica M Bertagnolli; Jian Zhou

doi:10.1002/lt.25887

Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

Liver Transpl. 2021 Feb;27(3):444-449. doi: 10.1002/lt.25887. Epub 2020 Dec 5.

Authors

Guo-Ming Shi^{1

2

3}, Jiping Wang⁴, Xiao-Wu Huang^{1

2

3}, Xiao-Yong Huang^{1

2

3}, Yi-Feng He^{1

2

3}, Yuan Ji⁵, Yi Chen^{1

2}, Dong Wu⁶, Jia-Cheng Lu^{1

2}, Qi-Man Sun^{1

2

3}, Wei-Ren Liu^{1

2

3}, Ting Wang⁷, Liu-Xiao Yang⁷, Ying-Yong Hou⁵, Ying-Hong Shi^{1

2

3}, Jian Sun^{1

2

3}, Yong-Sheng Xiao^{1

2

3}, Zheng Wang^{1

2

3}, Jia Fan^{1

2

8

9

3}, Monica M Bertagnolli⁴, Jian Zhou^{1

2

8

9

3}

Affiliations

¹ Department of Liver Surgery & TransplantationLiver Cancer Institute, Zhongshan Hospital, Fudan UniversityShanghaiChina.
² Key Laboratory of Carcinogenesis and Cancer InvasionMinistry of Education of the People's Republic of ChinaShanghaiChina.
³ Shanghai Key Laboratory of Organ TransplantationShanghaiChina.
⁴ Division of Surgical OncologyBrigham and Women's HospitalHarvard Medical SchoolBostonMA.
⁵ Department of PathologyZhongshan Hospital, Fudan UniversityShanghaiChina.
⁶ Department of RadiologyZhongshan Hospital, Fudan UniversityShanghaiChina.
⁷ Department of Critical Care MedicineZhongshan Hospital, Fudan UniversityShanghaiChina.
⁸ Cancer CenterInstitutes of Biomedical SciencesFudan UniversityShanghaiChina.
⁹ State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and DevelopmentSchool of Life SciencesFudan UniversityShanghaiChina.

PMID: 32897657
DOI: 10.1002/lt.25887

No abstract available

Publication types

Letter

MeSH terms

B7-H1 Antigen
Graft Rejection / prevention & control
Humans
Immunotherapy / adverse effects
Liver Neoplasms* / therapy
Liver Transplantation*

Substances

B7-H1 Antigen